ARCHIVES

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

NCI-Approved Clinical Trials

July 25, 2003

Army Breast Cancer Research Program Seeks Proposals

March 28, 1997

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

Examples Of CCOP Cancer Control Projects Listed

May 16, 1986

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992